2013
DOI: 10.1016/j.lpm.2012.04.026
|View full text |Cite
|
Sign up to set email alerts
|

Risque allergique en anesthésie

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 68 publications
0
3
0
Order By: Relevance
“…The incidence of anaphylaxis is estimated between 1 in 10,000 and 1 in 20,000 anesthetic procedures [ 2 , 3 ]. However, anaphylactic reactions cannot be clinically distinguished from non-immune mediated reactions which account for 30–40% of hypersensitivity reactions [ 1 , 8 ].…”
Section: Incidencementioning
confidence: 99%
See 1 more Smart Citation
“…The incidence of anaphylaxis is estimated between 1 in 10,000 and 1 in 20,000 anesthetic procedures [ 2 , 3 ]. However, anaphylactic reactions cannot be clinically distinguished from non-immune mediated reactions which account for 30–40% of hypersensitivity reactions [ 1 , 8 ].…”
Section: Incidencementioning
confidence: 99%
“…The potential occurrence of hypersensitivity reactions (IgE-mediated or non-IgE-mediated) is a great concern for anesthesiologists, because adverse reactions (ARs) may be very severe and life-threatening, with a mortality rate ranging from 3 to 9% [ 1 ]. Fatal anaphylaxis as well as a great proportion of less severe anaphylactic reactions is caused by drugs and substances related to general anesthesia [ 2 , 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…If neuromuscular blockers have been administered during the event, they should be excluded due to high rate of cross-reactivity, unless its administration is absolutely mandatory. Remember that cross-reactivity is more frequent among amino steroid blockers than among benzylisoquinoline derivatives 96 and that pancuronium (which has an inflexible structure) appears to be less likely to have cross-reactivity with other amino-steroids. For patients who suffered anaphylaxis with rocuronium and vecuronium, cisatracurium was found to be the agent that had the lowest rate of cross-reactivity to them 97 ;…”
Section: Appendixmentioning
confidence: 99%